• Oxford joins consortium to advance quantum drug discovery pharmatimes
    January 11, 2022
    The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order to reduce the development time required for drug production worldwide.
PharmaSources Customer Service